HLA-DRB1 typing in caucasians patients with neuromyelitis optica;HLA-DRB1 en pacientes caucásicos con neuromielitis óptica

Revista de Neurologia

Volumn 53, Issue 3, 2011, Pages 146-152

  Blanco, Yolanda ^a,b   Ercilla González, Guadalupe ^a   Llufriu, Sara ^a,b   Casanova Estruch, Bonaventura ^c   Jose Magraner M ^c   Ramió Torrentà, Lluís ^d   del Mar Mendibe Bilbao, M ^e   Uclés Sánchez, Antonio J ^f   Casado Chocán, José L ^f   de Munain, Adolfo López ^g   Ramo Tello, Cristina ^h   Santos Lasaosa, Sonia ⁱ   Porras, Ricardo Fernández Bolaños ^j   Segura Bruna, Nuria ^k   Sepúlveda Gázquez, María ^a,b   Villoslada, Pablo ^a,b   Graus, Francesc ^a,b   Saiz, Albert ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

^e HOSPITAL DE CRUCES   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^g HOSPITAL DONOSTIA   (Spain)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^j HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^k Hospital de la Linea de la Concepcion   (Spain)

more..

Author keywords

Aquaporin 4; Genetics; HLA Typing; Multiple sclerosis; Neuromyelitis optica; NMO IgG

Indexed keywords

AQUAPORIN 4; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FRANCE; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MYELOOPTIC NEUROPATHY; POPULATION; SPAIN; ALLELE; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; MULTIPLE SCLEROSIS;

ALLELES; AQUAPORIN 4; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; SPAIN;

EID: 79961120858     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5303.2011196     Document Type: Article

References (33)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-15.
2. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-12.
4. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005; 202: 473-7.
5. Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009; 386: 623-7.
6. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009; 66: 630-43.
7. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009; 66: 617-29.
8. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006; 15: 2813-24.
9. Brum DG, Barreira AA, Dos Santos AC, Kaimen-Maciel DR, Matiello M, Costa RM, et al. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult Scler 2010; 16: 21-9.
10. Deschamps R, Paturel L, Jeannin S, Chausson N, Olindo S, Béra O, et al. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population. Mult Scler 2011; 17: 24-31.
11. Isobe N, Matsushita T, Yamasaki R, Ramagopalan SV, Kawano Y, Nishimura Y, et al. Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status. Mult Scler 2010; 16: 147-55.
12. Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, Shi N, et al. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009; 73: 171-6.
13. Wang H, Dai Y, Qiu W, Zhong X, Wang Y, Lu Z, et al. HLA-DPB1*0501 is associated with susceptibility to antiaquaporin-4 antibodies positive neuromyelitis optica in Southern Han Chinese. J Neuroimmunol 2011; 233: 181-4.
14. Matiello M, Schaefer-Klein J, Brum DG, Atkinson EJ, Kantarci OH, Weinshenker BG, and the NMO genetics collaborators. HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica. Mult Scler 2010; 16: 981-4.
15. Zéphir H, Fajardy I, Outteryck O, Blanc F, Roger N, Fleury M, et al. Is neuromyelitis optica associated with human leukocyte antigen? Mult Scler 2009; 15: 571-9.
16. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9.
17. Saiz A, Zuliani L, Blanco Y, Tavolato B, Giometto B, Graus F. Revised diagnostic criteria for neuromyelitis optica (NMO). Application in a series of suspected patients. J Neurol 2007; 254: 1233-7.
18. Sabater L, Giralt A, Boronat A, Hankiewicz K, Blanco Y, Llufriu S, et al. Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: an in vitro study. J Neuroimmunol 2009; 215: 31-5.
19. Blanco Y, Hankiewicz K, Llufriu S, Sabater L, Graus F, Saiz A. Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG). Neurologia 2010; 25: 5-12.
20. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
21. Chiquete E, Navarro-Bonnet J, Ayala-Armas R, Gutiérrez- Gutiérrez N, Solórzano-Meléndez A, Rodríguez-Tapia D, et al. Neuromielitis óptica: actualización clínica. Rev Neurol 2010; 51: 289-94.
22. Ayuga-Loro F, Teijeira-Azcona A. Variabilidad clínica en la neuromielitis óptica: descripción de tres casos. Rev Neurol 2011; 52: 154-8.
23. Villoslada P, Barcellos LF, Río J, Begovich AB, Tintoré M, Sastre-Garriga J, et al. The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta. J Neuroimmunol 2002; 130: 194-201.
24. Ligeiro D, Fonseca JE, Abade O, Abreu I, Cruz M, Nero P, et al. Influence of human leucocyte antigen-DRB1 on the susceptibility to rheumatoid arthritis and on the production of anti-cyclic citrullinated peptide antibodies in a Portuguese population. Ann Rheum Dis 2007; 66: 246-8.
25. Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007; 3: 1607-13.
26. Tian C, Kosoy R, Nassir R, Lee A, Villoslada P, Klareskog L, et al. European population genetic substructure: further definition of ancestry informative markers for distinguishing among diverse European ethnic groups. Mol Med 2009; 15: 371-83.
27. Dittmar M, Ide M, Wurm M. Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur J Endocrinol 2008; 159: 55-60.
28. Hunt PJ, Marshall SE, Weetman AP, Bunce M, Bell JI, Wass JA, et al. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin Endocrinol 2001; 55: 491-9.
29. Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 2001; 11: 31-5.
30. Fernández O, Fernández V, Martínez-Cabrera V, Mayorga C, Alonso A, León A, et al. Multiple sclerosis in Gypsies from southern Spain: prevalence, mitochondrial DNA haplogroups and HLA class II association. Tissue Antigens 2008; 71: 426-33.
31. Fernández O, Rodríguez-Antigüedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol 2009; 256: 1977-88.
32. Cree BAC, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, et al. Modification of multiple sclerosis phenotypes by African ancestry at HLA. Arch Neurol 2009; 66: 226-33.
33. Ballerini C, Guerini FR, Rombolà G, Rosati E, Massacesi L, Ferrante P, et al. HLA-multiple sclerosis association in Continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004; 150: 178-85.